For patients experiencing chronic angina

Provide the possibility for better control

Indication
  • Ranexa is indicated for the treatment of chronic angina.
  • Ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.
Doctors Discuss Chronic Angina icon of message boxes

Watch cardiologists discuss the challenges of chronic angina and present the results of Ranexa clinical trials.

In this video, Dr. Deepak Talreja and Dr. Mateen Ahktar:

  • address the continuing clinical challenge of chronic angina
  • review the pivotal clinical trial for Ranexa–the CARISA Trial
  • provide an overview of the TERISA Trial
  • discuss treatment considerations and how Ranexa might be an appropriate option for your patients
  • explain Ranexa safety information
Financial Assistnace icon of dollar bill

Financial Assistance

Ranexa Connect is a financial assistance resource for patients with a Ranexa prescription.

Ranexa Connect is pleased to announce iAssist, a program to help start and support your patients on Ranexa. The program allows you to electronically enroll patients in Ranexa Connect.

iAssist program features include:

  • online patient enrollment and e-prescription
  • electronic signatures for prescribers and patients
  • real-time pharmacy benefit check and eligibility
Get Started Now
Dosing information icon of a pill bottle

Dosing

Understand available dosing and titration information, as well as important treatment considerations.

See Dosing Information
Safety data icon of a checkmark

Safety

Learn about safety data from the Ranexa clinical trials, including use in special populations.

Review Safety & Tolerability
Chronic Angina Burden on Patients icon of a heart

Chronic Angina Burden

Is the burden of angina under-recognized in your patients? Encourage open communication to help accurately assess the presence and frequency of your patients' angina.

Learn more about prevalence, symptom reporting, and recurrence post-PCI.

Understand the Challenges
Important Safety Information
Contraindications